Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Clinical trial NCT00136487 · COMPLETED

Trial details

NCT number: NCT00136487
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2002-10-01
Primary completion: 2006-09-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.